Atlas Trials

Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC

Clinical trial NCT04681469 · RECRUITING

Trial details

NCT number
NCT04681469
Sponsor
Gruppo Oncologico del Nord-Ovest
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2021-02-08
Primary completion
2023-06-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.